Hypomagnesemia and proton-pump inhibitors
- 21 May 2013
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 12 (5) , 709-716
Abstract
(2013). Hypomagnesemia and proton-pump inhibitors. Expert Opinion on Drug Safety: Vol. 12, No. 5, pp. 709-716. doi: 10.1517/14740338.2013.809062Keywords
This publication has 36 references indexed in Scilit:
- Proton pump inhibitors and hypomagnesemia: a rare but serious complicationKidney International, 2013
- Proton-pump inhibitor use is associated with low serum magnesium concentrationsKidney International, 2013
- Suboptimal magnesium status in the United States: are the health consequences underestimated?Nutrition Reviews, 2012
- Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting SystemInternational Journal of Medical Sciences, 2012
- Plasma and dietary magnesium and risk of sudden cardiac death in womenThe American Journal of Clinical Nutrition, 2011
- Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) StudyAmerican Heart Journal, 2010
- A Case Series of Proton Pump Inhibitor–Induced HypomagnesemiaAmerican Journal of Kidney Diseases, 2010
- Overprescribing proton pump inhibitorsBMJ, 2008
- Proton-Pump Inhibitors and Hypomagnesemic HypoparathyroidismNew England Journal of Medicine, 2006
- FUNCTIONAL HYPOPARATHYROIDISM AND PARATHYROID HORMONE END‐ORGAN RESISTANCE IN HUMAN MAGNESIUM DEFICIENCYClinical Endocrinology, 1976